small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search

Capabilities 79 results

Practice Area

Government Program Fraud, False Claims Act & Qui Tam Litigation

Investigations and litigation involving alleged fraud against the government pose a significant and growing threat to organizations and individuals across all industries that engage directly or indirectly in business with federal, state, and/or local governments. The government makes aggressive use of its extensive criminal and civil investigatory powers to root out alleged fraud and abuse implicating government funds, including one of its most powerful civil enforcement tools—the federal False Claims Act (FCA)—and similar state false claims statutes....Read more

Practice Area

Patent Litigation

Our Patent Litigation Practice is one of the country’s most active and highly regarded. Our seasoned patent litigators bring extensive courtroom experience to every matter we handle. According to Lex Machina, we are among the top three national patent defense firms in the country for number of appearances and cases filed, and we also were the top national defense firm for number of patent trials in the last five years (2018–2022)....Read more

Industry

Maritime & Admiralty

Insights & News 3,449 results

Benefits Blast

|

June 18, 2025

|

2 Min Read

Long-Term Part-Time Employee Retirement Plan Rules In Effect as of January 1, 2024

With the passage of the Setting Every Community Up for Retirement Enhancement Act of 2019 (SECURE Act) and the subsequent SECURE 2.0 Act (SECURE 2.0) in 2022, the last few years have been a time of upheaval, confusion, and ongoing disruption within the retirement plan space. 

Investigations, Enforcement, & Compliance Alerts

|

June 16, 2025

|

3 Min Read

DOJ’s June 9, 2025 FCPA Guidelines: A Recalibration of U.S. Anti-Corruption Enforcement

The long-anticipated guidance released by the U.S. Department of Justice (DOJ) on June 9, 2025 (the Guidelines) reorients Foreign Corrupt Practices Act (FCPA) enforcement, shifting the DOJ’s focus to more centrally controlled, national-interest-driven anti-corruption misconduct. Below is an overview of the background and salient shifts driven by the Guidelines.

Client Alert

|

June 12, 2025

|

3 Min Read

Reforming the Nuclear Regulatory Commission: An Overview of President Trump’s May 23 Executive Order

On May 23, 2025, President Trump signed an executive order titled “Ordering the Reform of the Nuclear Regulatory Commission” (EO) aimed at accelerating and expanding the nuclear energy industry in the United States. The EO directs a comprehensive structural reorganization of the Nuclear Regulatory Commission (NRC) and an overhaul of its regulatory framework related to the licensing and deployment of advanced nuclear reactors....Read more
View All Insights & News

Other Results 113 results

Law Glossary

What Are the Patent Litigation Differences Between the BPCIA and Hatch-Waxman Act?

There are fundamental differences between the abbreviated approval processes to obtain FDA approval for biosimilars and generic drugs as those processes relate to patent litigation....Read more

Law Glossary

What Is the Approval Process for Generic Drugs?

Approval for generic drugs are governed by the Hatch-Waxman Act. The Hatch-Waxman Act provides the framework for an applicant to demonstrate that its proposed generic product is bioequivalent to the brand-name drug....Read more

Site Content

The Corporate Transparency Act
Task Force

Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2025. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising